Thomas Olin
Chief Tech/Sci/R&D Officer presso KANCERA AB
Profilo
Thomas Olin is currently the Chief Executive Officer at iNovacia AB since 2006.
He is also a Director at Blasieholmen Investment Group AB.
In addition, he holds the position of Chief Scientific Officer & Executive VP at Kancera AB since 2010.
Previously, he served as the Chief Executive Officer & Director at SaltX Technology Holding AB.
He also worked as an Independent Director at Klaria Pharma Holding AB.
Prior to that, he was a Project Leader & Senior Researcher at Pharmacia & Upjohn, Inc. and an Area Manager-Nutrition Research at Pharmacia Hospital Care.
Posizioni attive di Thomas Olin
| Società | Posizione | Inizio |
|---|---|---|
| KANCERA AB | Chief Tech/Sci/R&D Officer | 01/07/2023 |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The private company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Chief Executive Officer | 01/01/2006 |
| Blasieholmen Investment Group AB | Director/Board Member | - |
Precedenti posizioni note di Thomas Olin
| Società | Posizione | Fine |
|---|---|---|
| KLARIA PHARMA HOLDING AB | Director/Board Member | - |
| Pharmacia Hospital Care | Corporate Officer/Principal | - |
| SALTX TECHNOLOGY HOLDING AB | Chief Executive Officer | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| KANCERA AB | Health Technology |
| SALTX TECHNOLOGY HOLDING AB | Electronic Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Aziende private | 4 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The private company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
| Pharmacia Hospital Care | |
| Blasieholmen Investment Group AB |
- Borsa valori
- Insiders
- Thomas Olin
